Title
Asymptomatic plasmodium vivax malaria in the brazilian amazon: Submicroscopic parasitemic blood infects nyssorhynchus darlingi
Date Issued
01 October 2021
Access level
open access
Resource Type
journal article
Author(s)
Almeida G.G.
Costa P.A.C.
Araujo M.d.S.
Gomes G.R.
Carvalho A.F.
Figueiredo M.M.
Pereira D.B.
Tada M.S.
Medeiros J.F.
Soares I.d.S.
Carvalho L.H.
Kano F.S.
de Castro M.C.
Golenbock D.T.
Do Valle Antonelli L.R.
Gazzinelli R.T.
Yale School of Medicine
Publisher(s)
Public Library of Science
Abstract
Individuals with asymptomatic infection due to Plasmodium vivax are posited to be important reservoirs of malaria transmission in endemic regions. Here we studied a cohort of P. vivax malaria patients in a suburban area in the Brazilian Amazon. Overall 1,120 individuals were screened for P. vivax infection and 108 (9.6%) had parasitemia detected by qPCR but not by microscopy. Asymptomatic individuals had higher levels of antibodies against P. vivax and similar hematological and biochemical parameters compared to uninfected controls. Blood from asymptomatic individuals with very low parasitemia transmitted P. vivax to the main local vector, Nyssorhynchus darlingi. Lower mosquito infectivity rates were observed when blood from asymptomatic individuals was used in the membrane feeding assay. While blood from symptomatic patients infected 43.4% (199/458) of the mosquitoes, blood from asymptomatic infected 2.5% (43/1,719). However, several asymptomatic individuals maintained parasitemia for several weeks indicating their potential role as an infectious reservoir. These results suggest that asymptomatic individuals are an important source of malaria parasites and Science and Technology for Vaccines granted by Conselho Nacional de may contribute to the transmission of P. vivax in low-endemicity areas of malaria.
Volume
15
Issue
10
Language
English
OCDE Knowledge area
Epidemiología
Scopus EID
2-s2.0-85118926907
PubMed ID
Source
PLoS Neglected Tropical Diseases
ISSN of the container
19352727
Sponsor(s)
ScienceandTechnologyforVaccinesgrantedby Conselho Nacional de Desenvolvimento Cientı ´fico e Tecnolo ´ gico(CNPq)/Fapemig/Coordenac ¸ãode Aperfeic ¸oamentodePessoaldeEnsinoSuperior (CAPES)(465293/2014-0),andCNPq/MS-SCTIE-Decit/Fundac ¸ãoBill&MelindaGates(442570/ 2019-8).Thefundershadnoroleinstudydesign, datacollectionandanalysis,decisiontopublish,or preparationofthemanuscript. RG was supported by the National Institutes of Health (R01AI079293, and U19 AI089681—Amazonian Center of Excellence in Malaria Research); Fundação de Amparo a Pesquisa de São Paulo (Fapesp, 2016/23618-8), Rede Mineira de Biomoléculas from Fundação de Amparo à Pesquisa de Minas Gerais (Fapemig, RED-00012-14), Brazilian National Institute of Science and Technology for Vaccines granted by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)/Fapemig/Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES) (465293/2014-0), and CNPq/MS-SCTIE-Decit/ Fundação Bill & Melinda Gates (442570/ 2019-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Sources of information: Directorio de Producción Científica Scopus